NASDAQ · PHVS
Pharvaris N.V.
Healthcare · Biotechnology
$30.49
Up+$0.63 (+2.07%)
Updated Oct 6, 2026, 9:38 PM
SID Score
3.9/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.56B
- P/E ratio
- -6.64
- Dividend yield
- 0.00%
- 52-week range
- $24.95 – $43.25
- Volume
- 816.23K
- Avg. volume
- 336.54K
Price performance · PHVS
PHVS price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 5, 2026
PHVS closed at $30.49 after 20 trading sessions, down 19.42% for the selected period.
- Last close
- $30.49
- Period change
- -19.42%
- Period low
- $30.49
- Period high
- $38.86
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 5, 2026 | $31.19 | $31.47 | $30.15 | $30.49 | 816.23K |
| Oct 2, 2026 | $31.21 | $31.55 | $30.69 | $31.19 | 591.39K |
| Oct 1, 2026 | $31.74 | $31.98 | $30.90 | $31.01 | 654.35K |
| Sep 30, 2026 | $31.84 | $32.05 | $31.14 | $31.72 | 839.84K |
| Sep 29, 2026 | $31.93 | $32.34 | $31.23 | $31.73 | 459.29K |
| Sep 28, 2026 | $32.00 | $32.46 | $31.39 | $31.91 | 753.33K |
| Sep 25, 2026 | $33.08 | $33.615 | $31.96 | $32.02 | 597.65K |
| Sep 24, 2026 | $32.88 | $33.84 | $31.91 | $32.99 | 949K |
| Sep 23, 2026 | $35.19 | $35.3082 | $32.87 | $33.07 | 654.29K |
| Sep 22, 2026 | $35.82 | $36.27 | $34.90 | $35.20 | 588.6K |
| Sep 21, 2026 | $36.33 | $36.88 | $35.50 | $36.02 | 653.74K |
| Sep 18, 2026 | $38.09 | $38.20 | $36.075 | $36.37 | 580.26K |
| Sep 17, 2026 | $37.81 | $38.93 | $37.595 | $38.00 | 1.14M |
| Sep 16, 2026 | $38.12 | $38.38 | $37.0003 | $37.55 | 829K |
| Sep 15, 2026 | $39.12 | $40.00 | $37.75 | $38.06 | 1.75M |
| Sep 14, 2026 | $38.16 | $40.46 | $38.10 | $38.86 | 998K |
| Sep 11, 2026 | $38.125 | $40.60 | $37.47 | $38.02 | 1.45M |
| Sep 10, 2026 | $37.60 | $39.03 | $37.00 | $37.51 | 1.32M |
| Sep 9, 2026 | $38.26 | $39.18 | $37.05 | $37.74 | 1.43M |
| Sep 8, 2026 | $40.96 | $43.25 | $37.60 | $37.84 | 6.33M |
Latest PHVS news
The latest Smart Investors Daily articles mentioning PHVS.
Stock researchMarket Activity · Options
Company
Market Activity
Research & News

